Interchange Capital Partners’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-472
Closed -$248K – 462
2026
Q2
$248K Buy
+472
New +$265K 0.05% 350
2022
Q2
– Sell
-439
Closed -$240K – 161
2022
Q1
$240K Buy
439
+62
+16% +$32.6K 0.25% 137
2021
Q4
$248K Buy
+377
New +$237K 0.25% 131
2021
Q2
– Sell
-430
Closed -$249K – 143
2021
Q1
$249K Sell
430
-82
-16% -$41.1K 0.14% 193
2020
Q4
$255K Hold
512
– – 0.14% 167

Other funds holding IDXX

Interchange Capital Partners's IDXX Position: Q3 2026 in Review

Interchange Capital Partners sold out of Idexx Laboratories (IDXX) in Q3 2026, closing a stake of 472 shares — an estimated $248K sold.

Interchange Capital Partners first reported a position in IDXX in Q4 2020 and held it in 5 quarters. The position peaked at $255K in Q4 2020. 1,281 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.

  • Interchange Capital Partners reported no remaining Idexx Laboratories position as of Q3 2026 after selling out during the quarter.
  • Interchange Capital Partners sold 472 Idexx Laboratories shares in Q3 2026, an estimated $248K.
  • Interchange Capital Partners first reported a position in Idexx Laboratories in Q4 2020 and held it in 5 quarters.
  • Interchange Capital Partners's Idexx Laboratories position peaked at $255K in Q4 2020.
  • 1,281 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.

Based on Interchange Capital Partners's 13F filing for Q3 2026, filed 28 Oct 2026.